Patient Dosing Resumes in Alzheimer’s Clinical Trial
January 20 2022 - 1:48PM
AllPennyStocks.com
Treatments for Alzheimer’s continue to be lacking in the
clinical community. A drug repurposing by the pharmaceutical
company has the potential to be an effective treatment for mild
to...
To read the full story on AllPennyStocks.com, click
here.
Intelgenx Technologies (TSX:IGX)
Historical Stock Chart
From May 2024 to Jun 2024
Intelgenx Technologies (TSX:IGX)
Historical Stock Chart
From Jun 2023 to Jun 2024